veliparib,pembrolizumab
merck,abbvie
[]
 nrg-gi002 of very-high risk locally adv #rectal adenoca (apr req d) updated results: addition of pembro to #tnt (induction folfox -&gt; lcrt + pembro) did not improve nar score or dfs but improves 3-yr os (95 vs 87%, hr 0.35) vs. control #gi23 
Medical oncologist and researcher in gastrointestinal and genitourinary cancers @CedarsSinai. Hematology/Oncology fellowship @cityofhope